The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population

被引:14
|
作者
Huang, Jieting [1 ,2 ]
Huang, Ke [1 ,2 ]
Xu, Ru [1 ,2 ]
Wang, Min [1 ,2 ]
Liao, Qiao [1 ,2 ]
Xiong, Huaping [1 ,2 ]
Li, Chengyao [3 ]
Tang, Xi [3 ]
Shan, Zhengang [1 ,2 ]
Zhang, Ming [4 ]
Rong, Xia [1 ,2 ]
Nelson, Kenrad [5 ]
Fu, Yongshui [1 ,2 ]
机构
[1] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China
[2] Key Med Disciplines & Specialties Program Guangzh, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Sch Biotechnol, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China
[4] Univ Georgia, Fac Infect Dis, Dept Epidemiol & Biostat, Athens, GA 30602 USA
[5] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
中国国家自然科学基金;
关键词
CLASS-II ALLELES; GENETIC-VARIATION; VIRAL CLEARANCE; HLA ALLELES; INFECTION; HCV; PERSISTENCE; GENOTYPE; HOST; DETERMINANTS;
D O I
10.1038/srep31485
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Spontaneous clearance of hepatitis C virus (HCV) occurs in 10-40% of the infections. Specific human leukocyte antigen (HLA) alleles have been identified in associating with HCV clearance. However, data on the association of HLA with the spontaneous clearance of HCV are scarce in the Chinese population. In the current study we studied the HLA class I and class II genes in 231 Chinese voluntary blood donors who had cleared HCV infection spontaneously compared to 429 subjects with chronic HCV infections. We also studied their IL28B SNP (rs8099917) genotype, since a number of investigators have found a strong association of IL28B with spontaneous or treatment induced HCV clearance. We found that HLA-A*02:01 and DQB1*05:02 distributed differently between the two groups after Bonferroni correction (odds ratio [OR] = 1.839, Pc = 0.024 and OR = 0.547, Pc = 0.016, respectively). Multivariate logistic regression analysis suggested that A*02:01 and DRB1*11:01 (OR = 1.798, P = 0.008 and OR = 1.921, P = 0.005, respectively) were associated with HCV spontaneous clearance, independent of age, gender and IL28B polymorphism. We concluded that in the Chinese population, HLA-A*02:01 and DRB1*11:01 might be associated with the host capacity to clear HCV independent of IL28B, which suggesting that the innate and adaptive immune responses both play an important role in the control of HCV.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment
    Morihara, Daisuke
    Ko, Yi-Ling
    Shibata, Kumiko
    Yamauchi, Ryo
    Fukuda, Hiromi
    Tsuchiya, Naoaki
    Fukunaga, Atsushi
    Kunimoto, Hideo
    Iwashita, Hideyuki
    Takata, Kazuhide
    Tanaka, Takashi
    Sakurai, Kunitoshi
    Inomata, Shinjiro
    Yokoyama, Keiji
    Nishizawa, Shinya
    Takeyama, Yasuaki
    Irie, Makoto
    Shakado, Satoshi
    Sohda, Tetsuro
    Sakisaka, Shotaro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (11) : 2019 - 2027
  • [42] Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
    Alestig, Erik
    Arnholm, Birgitta
    Eilard, Anders
    Lagging, Martin
    Nilsson, Staffan
    Norkrans, Gunnar
    Wahlberg, Thomas
    Wejstal, Rune
    Westin, Johan
    Lindh, Magnus
    BMC INFECTIOUS DISEASES, 2011, 11
  • [43] A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
    Prokunina-Olsson, Ludmila
    Muchmore, Brian
    Tang, Wei
    Pfeiffer, Ruth M.
    Park, Heiyoung
    Dickensheets, Harold
    Hergott, Dianna
    Porter-Gill, Patricia
    Mumy, Adam
    Kohaar, Indu
    Chen, Sabrina
    Brand, Nathan
    Tarway, McAnthony
    Liu, Luyang
    Sheikh, Faruk
    Astemborski, Jacquie
    Bonkovsky, Herbert L.
    Edlin, Brian R.
    Howell, Charles D.
    Morgan, Timothy R.
    Thomas, David L.
    Rehermann, Barbara
    Donnelly, Raymond P.
    O'Brien, Thomas R.
    NATURE GENETICS, 2013, 45 (02) : 164 - 171
  • [44] Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1
    Akkiz, Hikmet
    Akgollu, Ersin
    Bekar, Aynur
    Yildirim, Selcuk
    Sandikci, Macit
    Ulger, Yakup
    Kaya, Berrin Yalinbas
    Kuran, Sedef
    Uskudar, Oguz
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (06) : 711 - 717
  • [45] IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study
    Suppiah, Vijayaprakash
    Gaudieri, Silvana
    Armstrong, Nicola J.
    O'Connor, Kate S.
    Berg, Thomas
    Weltman, Martin
    Abate, Maria Lorena
    Spengler, Ulrich
    Bassendine, Margaret
    Dore, Gregory J.
    Irving, William L.
    Powell, Elizabeth
    Hellard, Margaret
    Riordan, Stephen
    Matthews, Gail
    Sheridan, David
    Nattermann, Jacob
    Smedile, Antonina
    Mueller, Tobias
    Hammond, Emma
    Dunn, David
    Negro, Francesco
    Bochud, Pierre-Yves
    Mallal, Simon
    Ahlenstiel, Golo
    Stewart, Graeme J.
    George, Jacob
    Booth, David R.
    PLOS MEDICINE, 2011, 8 (09)
  • [46] Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
    Kobayashi, Mariko
    Suzuki, Fumitaka
    Akuta, Norio
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Chayama, Kazuaki
    Miyakawa, Yuzo
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) : 596 - 605
  • [47] Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b
    Tsubota, Akihito
    Shimada, Noritomo
    Atsukawa, Masanori
    Abe, Hiroshi
    Kato, Keizo
    Ika, Makiko
    Matsudaira, Hiroshi
    Nagatsuma, Keisuke
    Matsuura, Tomokazu
    Aizawa, Yoshio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 144 - 150
  • [48] KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C
    Umemura, Takeji
    Ota, Masao
    Katsuyama, Yoshihiko
    Wada, Shuichi
    Mori, Hiromitsu
    Maruyama, Atsushi
    Shibata, Soichiro
    Nozawa, Yuichi
    Kimura, Takefumi
    Morita, Susumu
    Joshita, Satoru
    Komatsu, Michiharu
    Matsumoto, Akihiro
    Kamijo, Atsushi
    Kobayashi, Masakazu
    Takamatsu, Masato
    Yoshizawa, Kaname
    Kiyosawa, Kendo
    Tanaka, Eiji
    HUMAN IMMUNOLOGY, 2014, 75 (08) : 822 - 826
  • [49] The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype
    Rivero-Juarez, Antonio
    Lopez-Cortes, Luis F.
    Camacho, Angela
    Caruz, Antonio
    Torres-Cornejo, Almudena
    Martinez-Duenas, Loreto
    Ruiz-Valderas, Rosa
    Torre-Cisneros, Julian
    Gutierrez-Valencia, Alicia
    Rivero, Antonio
    AIDS, 2013, 27 (12) : 1941 - 1947
  • [50] IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection
    Lin, Chun-Yen
    Chen, Ji-Yih
    Lin, Tsung-Nan
    Jeng, Wen-Juei
    Huang, Chien-Hao
    Huang, Chang-Wen
    Chang, Su-Wei
    Sheen, I-Shyan
    PLOS ONE, 2011, 6 (03):